Nader joined Frazier Healthcare Partners in 1991 and has served on the firm’s Management Committee, Investment Committee, and led its Growth Buyout practice since 1995. Under his leadership, the Growth Buyout team has scaled from an initial group of four to over sixty dedicated professionals, and raised over $5 billion from Limited Partners globally for 10 investment vehicles.
During his three-decade plus tenure with the firm, he has been responsible for and served on the boards of successful investments in Aspen Education Group, CHG Healthcare, Priority Solutions International, Bravo Health, Laboratory Supply Company, Pentec Health, Solis Mammography, DSI Renal, and Northfield Medical. He currently serves on the Boards of United Digestive, Elevate Patient Financial Solutions, Accuity Delivery Systems, and Effective School Solutions.
Prior to joining Frazier, Nader was an Associate at Goldman Sachs in New York, and received his MBA from the Leonard N. Stern School of Business at New York University and a BA in Molecular Biology from the University of Pennsylvania.
New York University Stern School of Business (MBA)
University of Pennsylvania (BA, Molecular Biology)